AMORPHOUS AND CRYSTALLINE FORMS OF IDELALISIB AND PROCESS FOR FORMING THE SAME

摘要

The present invention concerns pure and stable amorphous idelalisib, crystalline solvates of idelalisib and a process for the formation of pure and stable amorphous idelalisib using the crystalline solvates of idelalisib.